Replies to post #8242 on Pluristem Therapeutics Inc (PSTI)

[JasperBoy]

I am not convinced zzzattt i am sure there are damn good scientists at the company but I don't see the clinical strategy.
In most if not all Small Biotechs the considered thinking is one or two indications and as quick to end of phase 3 as possible. Here they seem to be chasing as many indications hoping that one will hit or be sold. It may be a genius plan but as I said too much too thin with no revenue. I Expect to see more trials announced in the new year as the company explores therapeutic potential of R18 with no revenue this will be at the shareholders expense.
I am long but like many others not convinced and not happy